Draft Guidance for Industry on Vaginal Microbicides: Development for the Prevention of Human Immunodeficiency Virus Infection; Availability
Document ID: FDA-2012-D-1120-0001
Comments
Total: 6
-
Population Council - Comment
Posted : 02/21/2013 ID :FDA-2012-D-1120-0005 Agency : FDA -
Feb 21,2013 11:59 PM ET
-
Merck & Co, Inc. (Merck Research Laboratories) - Comment
Posted : 02/25/2013 ID :FDA-2012-D-1120-0006 Agency : FDA -
Feb 21,2013 11:59 PM ET
-
Christine K. Mauck (CONRAD) - Comment
Posted : 02/25/2013 ID :FDA-2012-D-1120-0007 Agency : FDA -
Feb 21,2013 11:59 PM ET
-
International Partnership for Microbicides (IPM) - Comment
Posted : 02/25/2013 ID :FDA-2012-D-1120-0008 Agency : FDA -
Feb 21,2013 11:59 PM ET
-
AVAC - Comment
Posted : 02/25/2013 ID :FDA-2012-D-1120-0009 Agency : FDA -
Feb 21,2013 11:59 PM ET
-
GlaxoSmithKline - Comment
Posted : 02/25/2013 ID :FDA-2012-D-1120-0010 Agency : FDA -
Feb 21,2013 11:59 PM ET